Pharming Group N.V. Files 6-K for Q2 Results
Ticker: PHAR · Form: 6-K · Filed: Jul 31, 2025 · CIK: 1828316
| Field | Detail |
|---|---|
| Company | Pharming Group N.V. (PHAR) |
| Form Type | 6-K |
| Filed Date | Jul 31, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, press-release, quarterly-report
TL;DR
Pharming Group dropped its Q2 earnings report on 7/31. Check the 6-K for details.
AI Summary
Pharming Group N.V. filed a Form 6-K on July 31, 2025, to furnish a press release regarding its second quarter financial results. The press release, dated July 31, 2025, is included as Exhibit 99.1 to this filing.
Why It Matters
This filing provides investors with timely updates on Pharming Group's financial performance for the second quarter of 2025, which can influence investment decisions.
Risk Assessment
Risk Level: low — This filing is a routine submission of a press release containing financial results, with no new material events or significant changes indicated.
Key Players & Entities
- Pharming Group N.V. (company) — Registrant
- July 31, 2025 (date) — Filing and Press Release Date
- 001-39822 (other) — Commission File Number
- 2333 CR Leiden The Netherlands (location) — Principal executive offices
FAQ
What is the purpose of this Form 6-K filing?
The purpose of this Form 6-K filing is to furnish a press release of Pharming Group N.V., dated July 31, 2025, which reports on the company's second quarter results.
What exhibit is included with this Form 6-K?
Exhibit 99.1, a press release from Pharming Group N.V. dated July 31, 2025, is furnished as part of this Form 6-K.
What period do the financial results in the press release cover?
The press release, furnished as Exhibit 99.1, reports on Pharming Group's second quarter results.
When was this Form 6-K filed?
This Form 6-K was filed on July 31, 2025.
What is Pharming Group N.V.'s principal executive office address?
Pharming Group N.V.'s principal executive offices are located at Darwinweg 24, 2333 CR Leiden, The Netherlands.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 31, 2025 regarding Pharming Group N.V. (PHAR).